Cargando…

Severe community acquired pneumonia: what should we predict?

Detalles Bibliográficos
Autores principales:	Renaud, Bertrand, Santin, Aline
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2784381/ https://www.ncbi.nlm.nih.gov/pubmed/19849826 http://dx.doi.org/10.1186/cc8111

Ejemplares similares

Risk stratification of early admission to the intensive care unit of patients with no major criteria of severe community-acquired pneumonia: development of an international prediction rule
por: Renaud, Bertrand, et al.
Publicado: (2009)

Bronchoalveolar lavage fluid dilution in ICU patients: what we should know and what we should do
por: Yu, Yuetian, et al.
Publicado: (2019)

Severity of community-acquired pneumonia treated with low-dose adjunctive corticosteroid
por: Mikami, Katsunaka, et al.
Publicado: (2011)

Multinational monkeypox outbreak: what do we know and what should we do?
por: Memariani, Mojtaba, et al.
Publicado: (2022)

Legionella pneumophila as Cause of Severe Community-Acquired Pneumonia, China
por: Yi, Huahua, et al.
Publicado: (2020)

Erythema nodosum: what should we consider about it?
por: Babamahmoudi, Farhang, et al.
Publicado: (2016)

Factors influencing severe community-acquired pneumonia few points to ponder
por: Pius, AK Aswin, et al.
Publicado: (2018)

Challenges in understanding host genetics and severity of community-acquired pneumonia
por: Solé-Violán, Jordi, et al.
Publicado: (2021)

Role of the eosinophil count in discriminating the severity of community-acquired pneumonia in HIV-infected patients
por: Perelló, Rafel, et al.
Publicado: (2008)

Severe community-acquired pneumonia
por: Morgan, AJ, et al.
Publicado: (2016)

Severe Community-Acquired Pneumonia
por: Khatib, Khalid, et al.
Publicado: (2019)

Severe Community-Acquired Pneumonia
por: Sligl, Wendy I., et al.
Publicado: (2013)

Severe community-acquired pneumonia
por: Niederman, Michael S., et al.
Publicado: (2022)

Clinicomicrobiological study of community-acquired pneumonia
por: Prasad, Prashasti, et al.
Publicado: (2017)

Aspergillus colonisation in severe community-acquired pneumonia: not just a mere colonisation
por: Pineau, Valentin, et al.
Publicado: (2023)

Corticosteroids in severe community-acquired pneumonia: the path we choose depends on where we want to get
por: Salluh, Jorge IF, et al.
Publicado: (2011)

What’s new in severe community-acquired pneumonia? Corticosteroids as adjunctive treatment to antibiotics
por: Torres, Antoni, et al.
Publicado: (2015)

In reply: efficacy of a new videolaryngoscope; what we should assess?
por: Asai, Takashi, et al.
Publicado: (2012)

Autonomous Sensory Meridian Response: What is It? and Why Should We Care?
por: Lloyd, James V., et al.
Publicado: (2017)

What Should We Do to Help Lessen Older Patients’ Pain?
por: Kim, Sun-Wook
Publicado: (2020)

Prescribing COVID-19 treatments: what we should never forget
por: Tunesi, S., et al.
Publicado: (2020)

Coronavirus Disease 2019 or Lung Cancer: What Should We Treat?
por: Russano, Marco, et al.
Publicado: (2020)

Negative patch tests: what should we think about these results?()
por: Starck, Mellanie, et al.
Publicado: (2022)

Advances in severe community-acquired pneumonia
por: Wang, Jian, et al.
Publicado: (2019)

Ceftaroline in severe community-acquired pneumonia
por: Cilloniz, Catia, et al.
Publicado: (2022)

Supporting hemodynamics: what should we target? What treatments should we use?
por: Gattinoni, Luciano, et al.
Publicado: (2013)

What is the Role of Respiratory Viruses in Community-Acquired Pneumonia?: What is the Best Therapy for Influenza and Other Viral Causes of Community-Acquired Pneumonia?
por: Pavia, Andrew T.
Publicado: (2013)

Do fluoroquinolones actually increase mortality in community-acquired pneumonia?
por: Agarwal, Ritesh
Publicado: (2006)

Should We Prescribe Antibiotics in Older Patients Presenting COVID-19 Pneumonia?
por: Odille, Geoffrey, et al.
Publicado: (2021)

Can we recognize severe community-acquired pneumonia without pneumonia severity index? Use of modified qSOFA with procalcitonin
por: Güleç, Tolgahan, et al.
Publicado: (2023)

Rapidly Progressive COVID-19 Pneumonia: What Radiologists Should Do
por: Chae, Kum Ju, et al.
Publicado: (2020)

What Should We Eat?
Publicado: (1909)

What All We Should Know About Masks in COVID-19 Pandemic
por: Agrawal, Himanshu, et al.
Publicado: (2020)

Should We Use DSI or not—What does the PADIS 2018 Guidelines Recommend?
por: Sharma, Ankur, et al.
Publicado: (2019)

Covid-19 pandemic and head and neck cancers, what should we expect?
por: Pucci, Resi, et al.
Publicado: (2021)

What should we realistically expect from robotic bronchoscopy in the near future?
por: Ho, Elliot, et al.
Publicado: (2021)

Validation of a Prediction Rule for Prognosis of Severe Community-Acquired Pneumonia
por: Leroy, Olivier, et al.
Publicado: (2008)

Scored minor criteria for severe community-acquired pneumonia predicted better
por: Guo, Qi, et al.
Publicado: (2019)

Predictive value of copeptin as a severity marker of community-acquired pneumonia
por: Mohamed, Gamal Baheeg, et al.
Publicado: (2017)

One year after ICU admission for severe community-acquired pneumonia of bacterial, viral or unidentified etiology. What are the outcomes?
por: Sangla, Frédéric, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2078h80a7hibq4d3ud01p0iarb